Transcontinental Financials
This page shows Transcontinental (TCI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Transcontinental has an operating margin of -12.3%, meaning the company retains $-12 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -20.0% the prior year.
Transcontinental's revenue declined 5.7% year-over-year, from $49.9M to $47.1M. This contraction results in a growth score of 12/100.
Transcontinental carries a low D/E ratio of 0.22, meaning only $0.22 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
Transcontinental generates a 0.7% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 3/100. This is up from 0.7% the prior year.
Transcontinental passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Transcontinental generates $0.22 in operating cash flow ($1.3M OCF vs $5.9M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Transcontinental earns $-0.8 in operating income for every $1 of interest expense (-$5.8M vs $7.6M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Transcontinental generated $47.1M in revenue in fiscal year 2024. This represents a decrease of 5.7% from the prior year.
Transcontinental's EBITDA was $6.8M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 47.6% from the prior year.
Transcontinental reported $5.9M in net income in fiscal year 2024. This represents a decrease of 1.3% from the prior year.
Transcontinental earned $0.68 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 1.4% from the prior year.
Transcontinental held $19.9M in cash against $181.9M in long-term debt as of fiscal year 2024.
Transcontinental paid $0.00 per share in dividends in fiscal year 2024.
Transcontinental had 9M shares outstanding in fiscal year 2024. This represents an increase of 0.0% from the prior year.
Transcontinental's operating margin was -12.3% in fiscal year 2024, reflecting core business profitability. This is up 7.7 percentage points from the prior year.
Transcontinental's net profit margin was 12.4% in fiscal year 2024, showing the share of revenue converted to profit. This is up 0.6 percentage points from the prior year.
Transcontinental's ROE was 0.7% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 0.0 percentage points from the prior year.
TCI Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.8M+5.6% | $12.2M+1.3% | $12.0M+1.8% | $11.8M+1.6% | $11.6M-1.4% | $11.8M-1.1% | $11.9M-11.6% | $13.5M |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $1.6M+15.3% | $1.4M+2.3% | $1.4M-12.7% | $1.5M+26.7% | $1.2M-13.5% | $1.4M+12.1% | $1.3M-7.5% | $1.4M |
| Operating Income | -$1.4M-69.2% | -$825K-29.9% | -$635K+62.4% | -$1.7M-1.3% | -$1.7M-54.3% | -$1.1M+18.8% | -$1.3M+37.4% | -$2.1M |
| Interest Expense | $1.7M-5.0% | $1.7M-2.4% | $1.8M-3.0% | $1.8M-11.5% | $2.1M+11.4% | $1.9M-0.4% | $1.9M-0.4% | $1.9M |
| Income Tax | $1.6M-23.0% | $2.0M+54.5% | $1.3M+1080.4% | $112K-79.5% | $546K-18.4% | $669K+10.9% | $603K+186.3% | -$699K |
| Net Income | $724K+328.4% | $169K-96.3% | $4.6M+4175.9% | $108K-93.7% | $1.7M+14.0% | $1.5M-41.2% | $2.5M+199.5% | -$2.6M |
| EPS (Diluted) | $0.08+300.0% | $0.02-96.2% | $0.53+5200.0% | $0.01-95.0% | $0.20+17.6% | $0.17-43.3% | $0.30+200.0% | $-0.30 |
TCI Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.1B+0.7% | $1.1B+4.0% | $1.1B+1.2% | $1.1B+1.3% | $1.1B+0.9% | $1.0B+0.4% | $1.0B-0.1% | $1.0B |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $11.9M-23.0% | $15.4M+12.1% | $13.8M-30.8% | $19.9M-49.6% | $39.5M-14.2% | $46.0M-15.8% | $54.7M+48.9% | $36.7M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $276.7M+2.6% | $269.6M+19.0% | $226.6M+4.1% | $217.7M+6.7% | $204.1M+4.0% | $196.1M+1.5% | $193.2M-1.5% | $196.1M |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | $223.5M+5.2% | $212.4M+7.2% | $198.2M+9.0% | $181.9M+0.9% | $180.3M+1.6% | $177.4M-0.5% | $178.3M-0.5% | $179.1M |
| Total Equity | $838.4M+0.1% | $837.7M0.0% | $837.3M+0.6% | $832.3M0.0% | $832.2M+0.2% | $830.4M+0.2% | $828.9M+0.3% | $826.0M |
| Retained Earnings | $576.3M+0.1% | $575.6M0.0% | $575.4M+0.8% | $570.8M0.0% | $570.7M+0.3% | $569.0M+0.3% | $567.5M+0.5% | $564.9M |
TCI Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $8.2M+380.2% | -$2.9M+60.8% | -$7.4M+52.8% | -$15.7M-214.9% | $13.7M+2780.8% | -$511K-113.2% | $3.9M+109.9% | -$38.9M |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$23.8M-170.1% | -$8.8M+47.1% | -$16.6M-15.2% | -$14.4M+40.0% | -$24.1M-64.9% | -$14.6M-226.1% | $11.6M-68.2% | $36.4M |
| Financing Cash Flow | $11.1M-20.5% | $13.9M-10.9% | $15.6M+896.2% | $1.6M-36.0% | $2.4M+372.5% | -$898K+38.3% | -$1.5M+17.3% | -$1.8M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
TCI Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | -10.9%-4.1pp | -6.8%-1.5pp | -5.3%+9.0pp | -14.3%+0.1pp | -14.4%-5.2pp | -9.2%+2.0pp | -11.2%+4.6pp | -15.8% |
| Net Margin | 5.6%+4.3pp | 1.4%-37.1pp | 38.5%+37.5pp | 0.9%-13.8pp | 14.7%+2.0pp | 12.7%-8.7pp | 21.4%+40.5pp | -19.0% |
| Return on Equity | 0.1%+0.1pp | 0.0%-0.5pp | 0.5%+0.5pp | 0.0%-0.2pp | 0.2%+0.0pp | 0.2%-0.1pp | 0.3% | N/A |
| Return on Assets | 0.1%+0.0pp | 0.0%-0.4pp | 0.4%+0.4pp | 0.0%-0.1pp | 0.2%+0.0pp | 0.1%-0.1pp | 0.2%+0.5pp | -0.3% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 0.27+0.0 | 0.25+0.0 | 0.24+0.0 | 0.220.0 | 0.220.0 | 0.210.0 | 0.220.0 | 0.22 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is Transcontinental's annual revenue?
Transcontinental (TCI) reported $47.1M in total revenue for fiscal year 2024. This represents a -5.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Transcontinental's revenue growing?
Transcontinental (TCI) revenue declined by 5.7% year-over-year, from $49.9M to $47.1M in fiscal year 2024.
Is Transcontinental profitable?
Yes, Transcontinental (TCI) reported a net income of $5.9M in fiscal year 2024, with a net profit margin of 12.4%.
What is Transcontinental's earnings per share (EPS)?
Transcontinental (TCI) reported diluted earnings per share of $0.68 for fiscal year 2024. This represents a -1.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Transcontinental's EBITDA?
Transcontinental (TCI) had EBITDA of $6.8M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Transcontinental have?
As of fiscal year 2024, Transcontinental (TCI) had $19.9M in cash and equivalents against $181.9M in long-term debt.
What is Transcontinental's operating margin?
Transcontinental (TCI) had an operating margin of -12.3% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Transcontinental's net profit margin?
Transcontinental (TCI) had a net profit margin of 12.4% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Transcontinental's return on equity (ROE)?
Transcontinental (TCI) has a return on equity of 0.7% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Transcontinental's operating cash flow?
Transcontinental (TCI) generated $1.3M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Transcontinental's total assets?
Transcontinental (TCI) had $1.1B in total assets as of fiscal year 2024, including both current and long-term assets.
How many shares does Transcontinental have outstanding?
Transcontinental (TCI) had 9M shares outstanding as of fiscal year 2024.
What is Transcontinental's debt-to-equity ratio?
Transcontinental (TCI) had a debt-to-equity ratio of 0.22 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Transcontinental's return on assets (ROA)?
Transcontinental (TCI) had a return on assets of 0.5% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Transcontinental's Piotroski F-Score?
Transcontinental (TCI) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Transcontinental's earnings high quality?
Transcontinental (TCI) has an earnings quality ratio of 0.22x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Transcontinental cover its interest payments?
Transcontinental (TCI) has an interest coverage ratio of -0.8x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Transcontinental?
Transcontinental (TCI) scores 29 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.